INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 April 2012
Total net assets |
£119.8m |
NAV per share |
216p |
Share price |
184p |
Total value of unquoted investments |
£22.9m |
Total number of portfolio companies |
66 |
Cash |
6% NAV |
Cash committed and reserved to unquoted investments |
(5)% NAV |
Portfolio companies with < 1 year of cash |
10.48% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Aptiv Solutions |
6.1 4.7 |
Celgene Pharmaxis Teva |
4.4 3.9 3.8 |
Alexion |
3.6 |
EUSA |
3.6 |
Biogen Insulet Biomarin |
3.4 3.2 3.1 |
|
----------- |
Total |
39.8 |
Geographical Allocation |
% |
United States & Canada |
72 |
Europe |
14 |
Australia |
4 |
Israel |
4 |
Cash |
6 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
75 |
Unquoted |
19 |
Cash |
6 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
22 MAY 2012